The Peptide Company โ€“ Navbar

Tesamorelin 20mg

£69.99

Research peptide. For laboratory use only.

Availability: 100 in stock

SKU: TESAMORELIN20MG Category:

โš 
Strictly for Research Purposes Only
This product is not for human consumption, diagnostic, or therapeutic use. It is not approved by the FDA or MHRA. Purchase is restricted to qualified researchers and institutions. Misuse may result in account termination and legal action.

Purity
99.0%+

Form
Lyophilized Powder

Grade
Research Grade

Storage
2โ€“8ยฐC / -20ยฐC

๐Ÿ”ฌ Technical Specifications
Molecular Formula
C221H366N72O67S

Molecular Weight
5135.9 g/mol (free base)

Sequence
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Gln-Ser-Asn-Ala

Purity
99.0%+

Appearance
White to off-white lyophilized powder

Shelf Life
24 months from manufacturing date

Storage
2โ€“8ยฐC (refrigerated) or -20ยฐC (frozen) for long-term storage

Solubility
Soluble in sterile water or bacteriostatic water

Batch Traceability
Batch Number
TES-2024-001
Mfd. Date
2024-01-15

Exp. Date
2026-01-15

Manufactured in GMP-Certified Facilities. Certificate of Analysis available on request.

Shipping & Handling
โœ“ Shipped in temperature-controlled packaging
โœ“ Same-day dispatch for orders before 2PM
โœ“ Discrete, plain packaging

๐Ÿงช Scientific Background
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), designed to stimulate the pituitary gland to release growth hormone. It has been modified with an N-terminal hexenoyl group to enhance its stability and resistance to enzymatic degradation.
Mechanism of Action: Tesamorelin binds to GHRH receptors in the anterior pituitary, stimulating the release of growth hormone. This promotes the production of insulin-like growth factor-1 (IGF-1), which plays a key role in regulating metabolism, reducing visceral fat, and supporting tissue repair.
Key References
โ€ข Falutz J, et al. “Effects of Tesamorelin on Visceral Fat in HIV-Infected Patients with Lipodystrophy.” New England Journal of Medicine, 2010.
โ€ข Guaraldi G, et al. “Tesamorelin for the Treatment of HIV-Associated Lipodystrophy.” Current Opinion in HIV and AIDS, 2011.

Related Research Compounds
โ€ข CJC-1295
โ€ข GHRP-6
โ€ข Ipamorelin

Reviews

There are no reviews yet.

Be the first to review “Tesamorelin 20mg”

Your email address will not be published. Required fields are marked *

Shopping Cart
Scroll to Top

Age Verification Required

Access to this website is restricted to individuals 18 years of age or older. All products are strictly for research purposes only and not intended for human consumption.

Legal Notice: By entering this site, you confirm that you are purchasing peptides for legitimate research purposes in compliance with UK law.

If you do not meet these requirements, please exit this website immediately.

Please confirm the checkbox before entering.